ATE50566T1 - 5-cyanopyridine-2-diazohydroxide, basische salze und verfahren zu ihrer herstellung und anwendung. - Google Patents

5-cyanopyridine-2-diazohydroxide, basische salze und verfahren zu ihrer herstellung und anwendung.

Info

Publication number
ATE50566T1
ATE50566T1 AT85114440T AT85114440T ATE50566T1 AT E50566 T1 ATE50566 T1 AT E50566T1 AT 85114440 T AT85114440 T AT 85114440T AT 85114440 T AT85114440 T AT 85114440T AT E50566 T1 ATE50566 T1 AT E50566T1
Authority
AT
Austria
Prior art keywords
diazohydroxides
cyanopyridine
processes
preparation
compounds
Prior art date
Application number
AT85114440T
Other languages
English (en)
Inventor
David C Baker
Original Assignee
Univ Alabama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alabama filed Critical Univ Alabama
Application granted granted Critical
Publication of ATE50566T1 publication Critical patent/ATE50566T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT85114440T 1984-11-13 1985-11-13 5-cyanopyridine-2-diazohydroxide, basische salze und verfahren zu ihrer herstellung und anwendung. ATE50566T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/670,203 US4636564A (en) 1984-11-13 1984-11-13 5-cyanopyridine-2-diazohydroxide, basic salts and methods for production and use
EP85114440A EP0181636B1 (de) 1984-11-13 1985-11-13 5-Cyanopyridine-2-diazohydroxide, basische Salze und Verfahren zu ihrer Herstellung und Anwendung

Publications (1)

Publication Number Publication Date
ATE50566T1 true ATE50566T1 (de) 1990-03-15

Family

ID=24689433

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85114440T ATE50566T1 (de) 1984-11-13 1985-11-13 5-cyanopyridine-2-diazohydroxide, basische salze und verfahren zu ihrer herstellung und anwendung.

Country Status (10)

Country Link
US (1) US4636564A (de)
EP (1) EP0181636B1 (de)
JP (1) JPS61158967A (de)
AT (1) ATE50566T1 (de)
AU (1) AU576914B2 (de)
CA (1) CA1255654A (de)
DE (1) DE3576154D1 (de)
DK (1) DK159847C (de)
ES (1) ES8700238A1 (de)
ZA (1) ZA858315B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816468A (en) * 1984-11-13 1989-03-28 The University Of Alabama 5-cyanopyridine-2-diazohydroxide, basic salts and use
DE4301109A1 (de) * 1993-01-18 1994-07-21 Bayer Ag Verfahren zur Herstellung von 6-Amino-nicotinsäurenitrilen
ITMI20011495A1 (it) * 2001-07-12 2003-01-12 Pharmaproducts Uk Ltd Sali di calcio ad attivita' citotossica
CN107602456B (zh) * 2017-10-19 2021-04-06 北京印刷学院 偶氮吡啶盐化合物及制备方法

Also Published As

Publication number Publication date
JPH0146511B2 (de) 1989-10-09
AU576914B2 (en) 1988-09-08
DK159847C (da) 1991-05-13
DK514285D0 (da) 1985-11-07
JPS61158967A (ja) 1986-07-18
CA1255654A (en) 1989-06-13
US4636564A (en) 1987-01-13
DE3576154D1 (de) 1990-04-05
DK159847B (da) 1990-12-17
EP0181636A3 (en) 1987-04-01
EP0181636B1 (de) 1990-02-28
ES8700238A1 (es) 1986-10-01
AU4983585A (en) 1986-05-22
ZA858315B (en) 1986-10-29
EP0181636A2 (de) 1986-05-21
DK514285A (da) 1986-05-14
ES548791A0 (es) 1986-10-01

Similar Documents

Publication Publication Date Title
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
ATE53038T1 (de) Inositoltriphosphat, verfahren zu seiner herstellung und dieses enthaltende zubereitung.
DE3582952D1 (de) Dihydropyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
EP0279149A3 (en) Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same
DE68909412D1 (de) Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.
ATE7228T1 (de) Imidazolinderivat, dessen salze, verfahren zur herstellung und dessen pharmazeutische zusammensetzungen.
ATE50566T1 (de) 5-cyanopyridine-2-diazohydroxide, basische salze und verfahren zu ihrer herstellung und anwendung.
ES8200678A1 (es) Un procedimiento para la produccion de 10-(4-piperidinil)-10, 11-dihidro-dibenzo b,f 1,4 oxarepinas; tiazepinas y diaze-pinas.
ATE32897T1 (de) Pyrazolo(3,4,5-kl)acridinderivate, pharmazeutische zubereitungen die sie enthalten und verfahren zu ihrer herstellung.
DE68918597D1 (de) Neues S-Timolol Derivat und Verfahren zu seiner Herstellung.
DE68917049D1 (de) Furylthiazol-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.
DE3586817D1 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES8601200A1 (es) Un procedimiento para preparar compuestos de 3-(2-haloetil)-4-oxopirazolo-(5, 1-d)-1, 2, 3, 5-tetrazin-8-carboxamida
ATE50567T1 (de) Diazohydroxypyrazinverbindungen, verfahren zu deren herstellung und verwendung.
AT375940B (de) Verfahren zur herstellung neuer 10-halogen-14-oxo-15-hydroxy-e-homoeburnane (3 alpha,17 alpha) sowie deren epimeren, optisch aktiven antipoden und physiologisch vertraeglichen saeureadditionssalze
ES8605261A1 (es) Un procedimiento para la preparacion de 1,4-aminoalquilamino-9-h-tioxaten-9-onas.
ATE133177T1 (de) 3'-deamino-4'-deoxy-4'-amino-8-fluoranthracycli e und verfahren zu ihrer herstellung
DE3767533D1 (de) D-nor-7-ergolinderivate, verfahren zu ihrer herstellung, pharmazeutische zubereitung und verwendung.
EP0154886A3 (de) Carboxyalkyldipeptidderivate, Verfahren zu deren Herstellung, diese enthaltende Mittel und deren Verwendung
DE3888697D1 (de) 2,3-thiomorpholinedion-2-oxim-derivate, arzneimittelzusammensetzungen und verfahren zur herstellung.
DE3689086D1 (de) 1,4-dihydropyridin-derivate, verfahren zu ihrer herstellung, pharmazeutische zusammensetzung und ihre verwendung.
ATE32514T1 (de) 3-(4'-aminobutylamino)-propylamino-bleomycinderivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE97660T1 (de) Pharmakologisch wirksame 3-substituierte 1,5diaryl-pyrazole und verfahren zu ihrer herstellung.
MX9603891A (es) Compuestos de 9-desoxotaxano.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee